Search results for "Bio"

AI Tracks Lung Scarring: 4-Percentage-Point Rise in One Year Signals Danger

AI Tracks Lung Scarring: 4-Percentage-Point Rise in One Year Signals Danger

Researchers have established an artificial intelligence benchmark to quantify the progression of idiopathic pulmonary fibrosis as the lungs stiffen,...
White Frost on Ice Cream: Safe to Eat or Time to Toss?

White Frost on Ice Cream: Safe to Eat or Time to Toss?

On a hot summer day, a freezer stocked with ice cream is a welcome comfort. Many people, particularly when eating from large tubs, scoop straight...

"Can I Get TAVI, Too?": 11 Key Questions to Ask Before an Aortic Valve Procedure

Many patients with severe aortic valve stenosis delay treatment out of fear of open-heart surgery.
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia

Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia

OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C...
Antihistamines Provide Minimal Relief for Atopic Dermatitis Itch, Study Finds

Antihistamines Provide Minimal Relief for Atopic Dermatitis Itch, Study Finds

Antihistamines commonly used to ease itching from atopic dermatitis do not deliver a large enough benefit for patients...
Daegu Broadens Anti-Aging Focus Beyond Skin to Whole-Body Health

Daegu Broadens Anti-Aging Focus Beyond Skin to Whole-Body Health

The era of relying solely on cosmetic procedures to maintain youth is fading. Taking its place is "internal...
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors

Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors

Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival

Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival

Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...
French Cardiac Surgeon Brings Father 10,000 km to Seoul for Rare Dual-Donor Liver Transplant

French Cardiac Surgeon Brings Father 10,000 km to Seoul for Rare Dual-Donor Liver Transplant

When Mohamed El Kettani, a 64-year-old Moroccan-born dual citizen of France and Morocco, was told that a liver...